September 30, 2016 / 1:26 PM / 10 months ago

BRIEF-Emergent awarded BARDA contract for advanced development of NuThrax

1 Min Read

Sept 30 (Reuters) - Emergent Biosolutions Inc

* Awarded BARDA contract for advanced development and delivery of NuThrax, a next generation anthrax vaccine, valued at up to $1.6 billion

* Contract includes options for an additional clinical study and post-marketing commitments valued at $48 million

* Company anticipates that FDA could authorize NuThrax for emergency use as early as 2018

* Contract includes options for delivery of additional 7.5 million to 50 million doses of NuThrax, valued about $255 million to up to $1.4 billion Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below